Murarka Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.88 M
as on 10-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 39.02%
(FY 2023)
- Ebitda 47.47%
(FY 2023)
- Net Worth -1.30%
(FY 2023)
- Total Assets -2.61%
(FY 2023)
About Murarka Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.88 M, as per Ministry of Corporate Affairs (MCA) records.
Puneet Murarka, Lalita Murarka, and Pulak Murarka serve as directors at the Company.
- CIN/LLPIN
U24232WB2007PTC115195
- Company No.
115195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Murarka Chemicals Private Limited offer?
Murarka Chemicals Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Inorganic Acids, Chemical Reagents & Catalysts, Potassium Salts, Oxidizing Agent, Flavours & Aromatics, Food Acidulant.
Who are the key members and board of directors at Murarka Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalita Murarka  | Director | 16-Apr-2007 | Current |
| Puneet Murarka | Director | 16-Apr-2007 | Current |
| Pulak Murarka | Director | 24-Jun-2014 | Current |
Financial Performance of Murarka Chemicals.
Murarka Chemicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 39.02% increase in profit. The company's net worth dipped by a decrease of 1.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Murarka Chemicals?
Unlock access to Murarka Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Murarka Chemicals?
Unlock and access historical data on people associated with Murarka Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Murarka Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Murarka Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
